Statins and Risk of Myocardial Infarction in Real Life in France

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00679575

Enrollment

13171

Registered

2008-05-19

Start date

2007-03-31

Completion date

2010-11-30

Last updated

2010-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

statins, myocardial infarction, case-referent study, France

Brief summary

The main objective of this case-referent study is to assess the impact of statins usage on the risk of having a first myocardial infarction (MI) in a real life situation in France

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients can speak French or English * Patients can be interviewed by telephone * Place of usual residence in the area of recruitment

Exclusion criteria

* Patients refusing to participate in the study * Patients who cannot be reached by telephone * Previous history of myocardial infarction

Design outcomes

Primary

Measure	Time frame
Assess the impact of the different statins (molecules) usage on the risk of having a first myocardial infarction in a real life situation in France	in 2011

Secondary

Measure	Time frame
Assess the interaction between statin treatment and risk factors such as cholesterol, age, gender, tobacco, alcohol, co-prescriptions, co-morbidities	in 2011
Assess the populational impact of statins usage on the risk of having a first myocardial infarction	in 2011
Assess the risk of having a first myocardial infarction according to high and low dosages of statins	in 2011

Countries

France

Outcome results